126 related articles for article (PubMed ID: 72471)
1. HLA antigens in Graves' disease.
Bech K; Lumholtz B; Nerup J; Thomsen M; Platz P; Ryder LP; Svejgaard A; Siersbaek-Nielsen K; Hansen JM; Larsen JH
Acta Endocrinol (Copenh); 1977 Nov; 86(3):510-6. PubMed ID: 72471
[TBL] [Abstract][Full Text] [Related]
2. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
3. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
4. [HLA DRW3 and Graves' disease (author's transl)].
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
Ann Endocrinol (Paris); 1980; 41(1):70-2. PubMed ID: 6893111
[TBL] [Abstract][Full Text] [Related]
5. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
Farid NR; Barnard JM; Marshall WH
Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
[TBL] [Abstract][Full Text] [Related]
6. HLA antigens and thyroid autoantibodies in patients with Graves' disease and their first degree relatives.
Mather BA; Roberts DF; Scanlon MF; Mukhtar ED; Davies TF; Smith BR; Hall R
Clin Endocrinol (Oxf); 1980 Feb; 12(2):155-63. PubMed ID: 6893172
[TBL] [Abstract][Full Text] [Related]
7. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
8. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
[TBL] [Abstract][Full Text] [Related]
9. HLA antigens in Asian Indian patients with Graves' disease.
Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
[TBL] [Abstract][Full Text] [Related]
10. [HLA B8 and Graves' disease (author's transl)].
Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
Ann Endocrinol (Paris); 1976; 37(4):219-26. PubMed ID: 1037358
[TBL] [Abstract][Full Text] [Related]
11. The operation of immunological networks in Graves' disease.
Farid NR; Newton RM; Noel EP; Barnard JM; Marshall WH
Tissue Antigens; 1978 Sep; 12(3):205-11. PubMed ID: 83018
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
[TBL] [Abstract][Full Text] [Related]
13. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
Lacka K; Kordel M; Gembicki M
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
[TBL] [Abstract][Full Text] [Related]
14. TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.
Schernthaner G; Ludwig H; Schleusener H; Finke R; Kotulla P; Mayr WR
Experientia; 1979 Oct; 35(10):1408-9. PubMed ID: 227717
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease and HLA: clinical and epidemiologic associations.
Farid NR; Stone E; Johnson G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
[TBL] [Abstract][Full Text] [Related]
16. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
17. The HLA B w4/w6 diallelic system in Graves' disease.
Farid NR; Barnard JM; Sampson L; Noel EP; Marshall WH
Tissue Antigens; 1978 May; 11(5):394-8. PubMed ID: 581239
[TBL] [Abstract][Full Text] [Related]
18. Prediction of remission after antithyroid drug treatment in Graves' disease.
Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
20. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
